Kauffman Fellows

Flash provides flexible benefits solutions. The company reinvented food vouchers by combining a MasterCard, a popular app, and an HR platform into a single device. Flash was founded in 2019 and is headquartered in So Paulo, SP.

ICON is a construction technology company that uses 3D robotics, software, and advanced materials.

Sidecar Health is an insurtech company that provides a personalized health insurance platform. Its platform offers customizable plans based on coverage needs and budget while being completely transparent about medical costs and payouts with comparable coverage and permits fast and easy transactions through a credit card to charge medical expenses upfront at the doctor's office and pharmacy of their choice, enabling consumers to get suitable and affordable health insurance plans.

Tally is a consumer tech company pioneering full-service financial automation. Founded in 2015, we built the first automated debt manager to help people overcome credit card debt and put billions of dollars back in people’s pockets. Tally’s vision is to automate people’s entire financial lives, so they can stress less about money and do more of what they love.

Carta is a transfer agent for private companies that enables seed-stage to pre-IPO companies to manage equity electronically with the participation of their shareholders, employees, auditors, and legal counsel. It digitizes paper stock certificates along with stock options, warrants, and derivatives to create a real-time image of who owns what at a startup.

Groww is an investment platform that offers a new way of investing money with stockbroking and direct mutual funds. The platform provides insights about mutual funds, systematic investment planning, equity-linked savings, and everything from the personal finance world, which helps new investors make investing simple by maintaining a simplified user interface to make investing easy, accessible, transparent, and paperless, enabling users to invest in mutual funds without any hassles. Customers can also invest in gold and US stocks through the Groww platform. The company is also a part of Y Combinator’s winter 2018 batch. Founded in 2017 by Lalit Keshre, Harsh Jain, Neeraj Singh, and Ishan Bansal, the company was launched in Bengaluru, Karnataka.

Groww is an investment platform that offers a new way of investing money with stockbroking and direct mutual funds. The platform provides insights about mutual funds, systematic investment planning, equity-linked savings, and everything from the personal finance world, which helps new investors make investing simple by maintaining a simplified user interface to make investing easy, accessible, transparent, and paperless, enabling users to invest in mutual funds without any hassles. Customers can also invest in gold and US stocks through the Groww platform. The company is also a part of Y Combinator’s winter 2018 batch. Founded in 2017 by Lalit Keshre, Harsh Jain, Neeraj Singh, and Ishan Bansal, the company was launched in Bengaluru, Karnataka.

Catalog is a developer of a data conversion and storage platform used to offer the next generation of digital data archives and computation. Its platform facilitates the encoding of data and information into DNA format and makes it economically attractive to use DNA as the major medium for long-term archival of data that enables customers to store digital information in DNA molecules. It brings cutting-edge synthetic biology technologies to the world of information storage and computation. The company was founded in 2016 and is headquartered in Boston, Massachusetts.

Zoom is a software company that offers a communications platform that connects people through video, voice, chat, and content sharing. It has an easy, reliable cloud platform for video and audio conferencing, collaboration, chat, and webinars across mobile devices, desktops, telephones, and room systems.

Ligandal's mission is to create precision delivery platform to cure and treat disease. We are driving the discovery and delivery of a broad array of gene therapies, genetic materials, and gene-specific payloads with unprecedented precision at the cellular and sub-cellular level. Our ligand discovery engine allows for rapid design of diagnostically-responsive materials, capable of shuttling a variety of nucleic acid and protein payloads (including CRISPR and mRNA) to specific cell types. We are initially applying this technology to indications in hematology, immuno-oncology, and infectious disease.